CD4 and infection: Further characterization of TBEV-specific CD4+ T cell response after an inactivated formalin-inactivated TBEV vaccine (FSME-Immun® 0.5 mL, Baxter, Deerfield, IL, USA) in comparison to the response raised by natural infection were performed.